Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
ZOOZ Announces Private Placement of $180 Million to Launch a Bitcoin Treasury Reserve Strategy
-
SAB BIO Announces Oversubscribed $175 Million Private Placement
-
Smith Micro Announces Closing of Follow-On Offering
-
Chardan Capital Markets Downgrades Clearside Biomedical (CLSD) to Neutral
-
Smith Micro raises $1.5 million through stock offering and warrants
-
Bit Origin raises $500 million to build dogecoin treasury strategy
-
Smith Micro Announces Follow-On Offering
-
Bit Origin Secures $500 Million Equity and Debt Facilities to Launch Dogecoin Treasury
-
Sonnet BioTherapeutics agrees to $888 million crypto treasury deal
-
Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy
-
Chardan Capital Markets Starts Urgent.ly (ULY) at Buy
-
Chardan: 'We think CRSP's emergence as a credible player in the space could thus drive further valuation upside'
-
Chardan Comments on iBio, Inc. (IBIO)
-
Forte Biosciences Announces Pricing of $75 Million Public Offering
-
Forte Biosciences (FBRX) Announces Proposed Share Offering
-
Forte Biosciences Announces Proposed Public Offering
-
Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program
-
Carisma Therapeutics (CARM) to Merge with Ocugen's (OCGN) OrthoCellix
-
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
-
Chardan Capital Markets Starts Monopar Therapeutics (MNPR) at Buy, PT $60
-
Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings
-
Lion Group Holding (LGHL) Secures $600M Facility to Launch Hyperliquid (HYPE) Treasury
-
LGHL Secures $600 Million Facility to Launch Hyperliquid (HYPE) Treasury
-
Wedbush Securities Expands Trading Leadership with the Hiring of Michael Bower and George Nikitiadis as Managing Directors
-
Eyenovia (EYEN) Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy
-
Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy
-
Chardan Capital Markets Reiterates Buy Rating on Dyne Therapeutics (DYN) Following FDA Update
-
Klotho Neurosciences (KLTO) Raises Over $11 Million, Retires All Debt, And Exceeds Nasdaq Stockholders' Equity Requirement
-
KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT
-
Senti Bio to Participate in a Virtual Fireside Chat Hosted by Chardan Capital Markets, LLC
-
Signify Bio Launches With an Oversubscribed $15 Million Initial Financing and Strategic Partnership With UTSW Focused on Nucleic Acid Enabled Protein Therapeutics
-
VivoPower (VVPR) and BitGo Partner to Facilitate its Initial $100M XRP Acquisition for Treasury Strategy
-
BitGo Enters Strategic Partnership with VivoPower to Facilitate its Initial $100 Million XRP Acquisition for Treasury Strategy
-
BitGo Enters Strategic Partnership with VivoPower (VVPR) to Facilitate its Initial US$100 Million XRP Acquisition for Treasury Strategy
-
BitGo Enters Strategic Partnership with VivoPower to Facilitate its Initial US$100 Million XRP Acquisition for Treasury Strategy
-
Classover Holdings (KIDZ) Completes Initial SOL Purchase and Enters into New Purchase Agreement to Sell up to $500M of Notes
-
Classover Completes Initial SOL Purchase and Enters into New Purchase Agreement to Sell up to $500 Million of Notes to Accelerate SOL Treasury Strategy
-
VivoPower (VVPR) Announces XRP-Focused Digital Asset Treasury Strategy and US$121 Million Private Placement Priced at US$6.05 Per Share
-
VivoPower Announces XRP-Focused Digital Asset Treasury Strategy and US$121 Million Private Placement Priced at US$6.05 Per Share, Above Last Market Closing Price Under NASDAQ Rules
-
Chardan Capital Markets Assumes CleanSpark Inc. (CLSK) at Buy
-
Prime Medicine (PRME) PT Lowered to $12 at Chardan Capital Markets
-
Chardan Capital Markets Reiterates Buy Rating on CervoMed (CRVO)
-
AB Science reports its revenues for the year 2024 and provides an update on its activities
-
Chardan Capital Markets Downgrades Seres Therapeutics (MCRB) to Neutral
-
Chardan Capital Markets Starts Bright Minds Biosciences Inc. (DRUG) at Buy
-
Chardan Capital Markets Starts Praxis Precision Medicines Inc. (PRAX) at Buy
-
Chardan Capital Markets Starts Xenon Pharmaceuticals (XENE) at Buy
-
iBio, Inc. (IBIO) Raises $6.2M Through Warrant Inducement Transaction
-
iBio Raises $6.2 Million Through Warrant Inducement Transaction
-
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

